Related Experiment Video
Updated: Jun 23, 2026

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
Published on: October 6, 2014
Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse
Qingjie Li1, Christiane V Löhr, Roderick H Dashwood
1Linus Pauling Institute, Oregon State University, Corvallis, OR 97331-6512, USA.
Abstract:
Activator protein 2alpha (AP-2alpha) is a putative tumor suppressor, and various reports have described the loss or reduction of AP-2alpha expression in cutaneous malignant melanomas, as well as in cancers of the prostate, breast and colon. Previously, AP-2alpha was shown to attenuate beta-catenin/T-cell factor-4 (TCF-4) nuclear interactions and beta-catenin/TCF-4-dependent transcriptional activity in human colorectal cancer cells [Q. Li, R.H. Dashwood, Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells, J. Biol. Chem. 279 (2004) 45669-45675]. Here, we show that in vivo gene delivery of AP-2alpha suppressed intestinal polyp formation in the Apc(min) mouse, and protected against the development of anemia and splenomegaly. Immunoblot analyses and immunohistochemistry following gene delivery revealed an increase in AP-2alpha expression in the mouse intestinal mucosa and liver. Co-immunoprecipitation experiments provided evidence for interactions between AP-2alpha, beta-catenin, and adenomatous polyposis coli (APC) proteins in mouse intestinal mucosa, as well as in a primary human colorectal cancer. Collectively, these studies support a tumor suppressor role for AP-2alpha in the gastrointestinal tract, and suggest that AP-2alpha represents a novel target for therapeutic intervention in human cancers characterized by dysregulated Wnt signaling.
Insights
Activator protein 2alpha (AP-2alpha) acts as a tumor suppressor. Gene delivery of AP-2alpha inhibited intestinal polyp formation in mice, supporting its therapeutic potential for cancers with Wnt pathway dysregulation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Activator protein 2alpha (AP-2alpha) is a potential tumor suppressor.
- Reduced AP-2alpha expression is observed in various cancers, including melanoma, prostate, breast, and colon cancers.
- AP-2alpha was previously shown to inhibit beta-catenin/T-cell factor-4 (TCF-4) transcriptional activity in colorectal cancer cells.
Purpose of the Study:
- To investigate the in vivo tumor suppressor role of AP-2alpha in the gastrointestinal tract.
- To explore AP-2alpha as a potential therapeutic target for cancers with Wnt signaling pathway dysregulation.
Main Methods:
- In vivo gene delivery of AP-2alpha into Apc(min) mice.
- Immunoblot analyses and immunohistochemistry to assess AP-2alpha expression.
- Co-immunoprecipitation assays to study protein interactions.
Main Results:
- Gene delivery of AP-2alpha suppressed intestinal polyp formation in Apc(min) mice.
- AP-2alpha delivery led to increased AP-2alpha expression in mouse intestinal mucosa and liver.
- Evidence of interactions between AP-2alpha, beta-catenin, and adenomatous polyposis coli (APC) proteins was found in mouse and human colorectal cancer samples.
Conclusions:
- AP-2alpha demonstrates a tumor suppressor role in the gastrointestinal tract.
- AP-2alpha represents a novel therapeutic target for human cancers with dysregulated Wnt signaling.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Anaphase Promoting Complex
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

